# The Impact of Co-Dispensing Naloxone to Patients Prescribed Chronic Opioid Therapy

> **NCT03337100** · NA · COMPLETED · sponsor: **Kaiser Permanente** · enrollment: 7 (actual)

## Conditions studied

- Overdose
- Risk Behavior

## Interventions

- **BEHAVIORAL:** Co-Dispensing

## Key facts

- **NCT ID:** NCT03337100
- **Lead sponsor:** Kaiser Permanente
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-11-27
- **Primary completion:** 2021-04-30
- **Final completion:** 2022-09-30
- **Target enrollment:** 7 (ACTUAL)
- **Last updated:** 2023-03-03

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03337100

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03337100, "The Impact of Co-Dispensing Naloxone to Patients Prescribed Chronic Opioid Therapy". Retrieved via AI Analytics 2026-05-31 from https://api.ai-analytics.org/clinical/NCT03337100. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*